The DOI matches its Crossref record; 65 of the 68 references it cites were found in a registry or an index.
Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
Open accessAbstract
In 2012, the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) published a position statement on the management of hyperglycemia in patients with type 2 diabetes (1,2). This was needed because of an increasing array of antihyperglycemic drugs and growing uncertainty regarding their proper selection and sequence. Because of a paucity of comparative effectiveness research on long-term treatment outcomes with many of these medications, the 2012 publication was less prescriptive than prior consensus reports. We previously described the need to individualize both treatment targets and treatment strategies, with an emphasis on patient-centered care and shared decision making, and this continues to be our position, although there are now more head-to-head trials that show slight variance between agents with regard to glucose-lowering effects. Nevertheless, these differences are often small and would be unlikely to reflect any definite differential effect in an individual patient. The ADA and EASD have requested an update to the position statement incorporating new data from recent clinical trials. Between June and September of 2014, the Writing Group reconvened, including one face-to-face meeting, to discuss the changes. An entirely new statement was felt to be unnecessary. Instead, the group focused on those areas where revisions were suggested by a changing evidence base. This briefer article should therefore be read as an addendum to the previous full account (1,2). Glucose control remains a major focus in the management of patients with type 2 diabetes. However, this should always be in the context of a comprehensive cardiovascular risk factor reduction program, to include smoking cessation and the adoption of other healthy lifestyle habits, blood pressure control, lipid management with priority to statin medications, and, in some circumstances, antiplatelet therapy. Studies have conclusively determined that reducing hyperglycemia decreases the onset and progression of …
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Strong evidence supports the ef fi cacy and cost-effectiveness of nutrition therapy as a component of quality diabetes care, including its integration into the medical management of diabetes”
From Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report (2019) · cites this paper as [2]
Citations
Cites
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751
Self-citationDormandy, J. A., Charbonnel, B., Eckland, D. J., Erdmann, E., Massi-Benedetti, M., Moules, I. K., Skene, A. M., Tan, M. H., Lefèbvre, P. J., Murray, G. D., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67528-9 · Cited by 4,129
Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2012) · Diabetologia · doi:10.1007/s00125-012-2534-0 · Cited by 3,919
Self-citationSaxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus
Scirica, B. M., Bhatt, D. L., Braunwald, E., Steg, P. G., Davidson, J., Hirshberg, B., Ohman, P., Frederich, R., Wiviott, S. D., Hoffman, E. B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1307684 · Cited by 3,470
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2012) · Diabetes Care · doi:10.2337/dc12-0413 · Cited by 3,207
Self-citationAlogliptin after acute coronary syndrome in patients with type 2 diabetes
White, W. B., Cannon, C. P., Heller, S. R., Nissen, S. E., Bergenstal, R. M., Bakris, G. L., Perez, A. T., Fleck, P. R., Mehta, C. R., Kupfer, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1305889 · Cited by 2,502
Self-citation
Cited by
Sorted by citations
Items 401–500 of 1,014
Li, D., Shi, W., Wang, T., & Tang, H. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13294 · Cited by 65
Muntner, P., Whelton, P. K., Woodward, M., & Carey, R. M. (2018) · Diabetes Care · doi:10.2337/dc18-1307 · Cited by 65
Systematic review of incretin therapy during peri-operative and intensive care
Hulst, A. H., Plummer, M. P., Hollmann, M. W., DeVries, J. H., Preckel, B., Deane, A. M., & Hermanides, J. (2018) · Critical Care · doi:10.1186/s13054-018-2197-4 · Cited by 65
Abrahami, D., Douros, A., Yin, H., Yu, O. H., Faillie, J., Montastruc, F., Platt, R. W., Bouganim, N., & Azoulay, L. (2018) · BMJ · doi:10.1136/bmj.k4880 · Cited by 66
Ku, E. J., Lee, D., Jeon, H. J., & Oh, T. K. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.04.008 · Cited by 65
Scheen, A. J. (2016) · Diabetes & Metabolism · doi:10.1016/j.diabet.2016.05.006 · Cited by 64
Epidemiology of Diabetes—Status of a Pandemic and Issues Around Metabolic Surgery
Zimmet, P. Z., & Alberti, K. G. M. M. (2016) · Diabetes Care · doi:10.2337/dc16-0273 · Cited by 64
Prevención en diabetes mellitus y riesgo cardiovascular: enfoque médico y nutricional
Pinilla-Roa, A. E., & Barrera, M. D. P. (2018) · Revista de la Facultad de Medicina · doi:10.15446/revfacmed.v66n3.60060 · Cited by 64
Rahhal, M.-N., Gharaibeh, N. E., Rahimi, L., & Ismail‐Beigi, F. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00286 · Cited by 64
Schernthaner, G., Durán-Garcia, S., Hanefeld, M., Langslet, G., NISKANEN, L. K., Östgren, C. J., Malvolti, E., & Hardy, E. (2015) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12461 · Cited by 64
Systematic review and meta-analysis of vildagliptin for treatment of type 2 diabetes
Bekiari, E., Rizava, C., Athanasiadou, E. A., Papatheodorou, K., Liakos, A., Karagiannis, T., Mainou, M., Rika, M., Boura, P., & Τσάπας, Α. (2015) · Endocrine · doi:10.1007/s12020-015-0841-1 · Cited by 64
Rodbard, H. W., Seufert, J., Aggarwal, N., Cao, A., Fung, A., Pfeifer, M. A., & Alba, M. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12684 · Cited by 64
Emral, R., Pathan, F., Yepes, C. A., El-Hefnawy, M. H., Goh, S., Gómez, A. M., Murphy, A., Abusnana, S., Rudijanto, A., Jain, A., et al. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.07.031 · Cited by 64
Abdul-Ghani, M. A., & DeFronzo, R. A. (2017) · Diabetes Care · doi:10.2337/dc16-2368 · Cited by 64
Jeong, J. Y., Jeon, J.-H., Bae, K.-H., Choi, Y.-K., Park, K.-G., Kim, J.-G., Won, K. C., Cha, B. S., Ahn, C. W., Kim, D. W., et al. (2018) · Telemedicine and e-Health · doi:10.1089/tmj.2017.0203 · Cited by 63
Freemantle, N., Chou, E., Frois, C., Zhuo, Y. D., Lehmacher, W., Vlajnic, A., Wang, H., Chung, H., Zhang, Q., Wu, E. Q., et al. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-009421 · Cited by 63
Assyov, Y. S., Gateva, A., Tsakova, A. D., & Kamenov, Z. A. (2016) · Endocrine Research · doi:10.3109/07435800.2016.1155598 · Cited by 63
Implantable batteryless device for on-demand and pulsatile insulin administration
Lee, S. H., Lee, Y. B., Kim, B. H., Lee, C., Cho, Y. M., Kim, S.-N., Park, C. G., Cho, Y.-C., & Choy, Y. B. (2017) · Nature Communications · doi:10.1038/ncomms15032 · Cited by 63
van Raalte, D. H., & Verchere, C. B. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12935 · Cited by 63
Therapeutic application of GPR119 ligands in metabolic disorders
Yang, J. W., Kim, H. S., Choi, Y., Kim, Y., & Kang, K. W. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13062 · Cited by 63
Kanto, K., Ito, H., Noso, S., Babaya, N., Hiromine, Y., Taketomo, Y., Toma, J., Niwano, F., Yasutake, S., Kawabata, Y., et al. (2017) · Journal of Diabetes Investigation · doi:10.1111/jdi.12755 · Cited by 63
Metformin monotherapy for adults with type 2 diabetes mellitus
Gnesin, F., Thuesen, A. C. B., Kähler, L. K. A., Madsbad, S., & Hemmingsen, B. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012906.pub2 · Cited by 63
Optimisation of follow-up after metabolic surgery
Mingrone, G., Bornstein, S. R., & le Roux, C. W. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30434-5 · Cited by 63
Peralta, F. G., Abreu, C., Rodríguez, S. G., Barranco, R. J., & Umpierrez, G. E. (2018) · Diabetes Therapy · doi:10.1007/s13300-018-0488-z · Cited by 63
Kalra, S., Das, A. K., Sahay, R. K., Baruah, M. P., TIWASKAR, M. H., Das, S., Chatterjee, S., Saboo, B., Bantwal, G., Bhattacharya, S., et al. (2019) · Diabetes Therapy · doi:10.1007/s13300-019-0669-4 · Cited by 64
Hausner, H., Derving Karsbøl, J., Holst, A. G., Jacobsen, J. B., Wagner, F.-D., Golor, G., & Anderson, T. W. (2017) · Clinical Pharmacokinetics · doi:10.1007/s40262-017-0532-6 · Cited by 62
Mottalib, A., Salsberg, V., Mohd-Yusof, B.-N., Mohamed, W., Carolan, P., Pober, D. M., Mitri, J., & Hamdy, O. (2018) · Nutrition Journal · doi:10.1186/s12937-018-0351-0 · Cited by 62
Importance of Postprandial Glucose in Relation to A1C and Cardiovascular Disease
Hershon, K. S., Hirsch, B. R., & Odugbesan, O. (2019) · Clinical Diabetes · doi:10.2337/cd18-0040 · Cited by 62
GLP-1 based therapies: clinical implications for gastroenterologists
Smits, M. M., van Raalte, D. H., Tonneijck, L., Muskiet, M. H. A., Kramer, M. H. H., & Cahen, D. L. (2016) · Gut · doi:10.1136/gutjnl-2015-310572 · Cited by 62
Zhong, V. W., Juhaeri, J., Cole, S. R., Kontopantelis, E., Shay, C. M., Gordon‐Larsen, P., & Mayer‐Davis, E. J. (2017) · Diabetes Care · doi:10.2337/dc16-2680 · Cited by 62
Ko, S., Hur, K.-Y., Rhee, S. Y., Kim, N. H., Moon, M. K., Park, S.-O., Lee, B., Kim, H. J., Choi, K. M., & Kim, J. H. (2017) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2017.41.5.337 · Cited by 62
Metformin-induced anticancer activities: recent insights
Safe, S. H., Nair, V., & Karki, K. (2017) · Biological Chemistry · doi:10.1515/hsz-2017-0271 · Cited by 62
Tobe, S. W., Stone, J. A., Anderson, T. J., Bacon, S., CHENG, A. Y. Y., Daskalopoulou, S. S., Ezekowitz, J. A., Grégoire, J. C., Gubitz, G. J., Jain, R., et al. (2018) · Canadian Medical Association Journal · doi:10.1503/cmaj.180194 · Cited by 62
Gilbert, M. P., Bain, S. C., Franek, E., Jódar-Gimeno, E., Nauck, M. A., Pratley, R. E., Rea, R. R., Saraiva, J. F. K., Rasmussen, S., Tornøe, K., et al. (2018) · Annals of Internal Medicine · doi:10.7326/m18-1569 · Cited by 62
Self-citationSloan, L. A. (2019) · Journal of Diabetes · doi:10.1111/1753-0407.12969 · Cited by 62
Pancreatic α-Cell Dysfunction in Type 2 Diabetes: Old Kids on the Block
Moon, J. S., & Won, K. C. (2015) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2015.39.1.1 · Cited by 61
Seufert, J. (2015) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s90662 · Cited by 61
Impact of Metformin Use on Lactate Kinetics in Patients with Severe Sepsis and Septic Shock
Park, J., Hwang, S. Y., Jo, I. J., Jeon, K., Suh, G. Y., Lee, T. R., Yoon, H. J., Cha, W. C., Sim, M. S., Carriere, K. C., et al. (2016) · Shock · doi:10.1097/shk.0000000000000782 · Cited by 61
Consensus statement on dose modifications of antidiabetic agents in patients with hepatic impairment
Gangopadhyay, K., & Singh, P. (2017) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_512_16 · Cited by 61
Tsirou, E., Grammatikopoulou, M. G., Theodoridis, X., Gkiouras, K., Petalidou, A., Taousani, E., Savvaki, D., Τσάπας, Α., & Goulis, D. G. (2019) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2019.04.002 · Cited by 61
Omidian, M., Mahmoudi, M., Abshirini, M., Eshraghian, M. R., Javanbakht, M. H., Zarei, M., Hasani, H., & Djalali, M. (2019) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2019.06.011 · Cited by 62
Simplifying Complex Insulin Regimens While Preserving Good Glycemic Control in Type 2 Diabetes
Taybani, Z. J., Bótyik, B., Katkó, M., Gyimesi, A., & Várkonyi, T. T. (2019) · Diabetes Therapy · doi:10.1007/s13300-019-0673-8 · Cited by 61
Dalal, M. R., Grabner, M., Bonine, N., Stephenson, J. J., DiGenio, A., & Bieszk, N. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.08.004 · Cited by 60
Heart Failure Considerations of Antihyperglycemic Medications for Type 2 Diabetes
Standl, E., Schnell, O., & McGuire, D. K. (2016) · Circulation Research · doi:10.1161/circresaha.116.306924 · Cited by 60
Efficacy and safety of insulin in type 2 diabetes: meta-analysis of randomised controlled trials
Erpeldinger, S., Rehman, M. B., Berkhout, C., Pigache, C., Zerbib, Y., Regnault, F., Guérin, É., Supper, I., Cornu, C., Kassaï, B., et al. (2016) · BMC Endocrine Disorders · doi:10.1186/s12902-016-0120-z · Cited by 60
García-Calzón, S., Perfilyev, A., Martinell, M., Ustinova, M., Kalamajski, S., Franks, P. W., Bacos, K., Elbere, I., Pihlajamäki, J., Volkov, P., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aaz1803 · Cited by 61
Hadi, A., Pourmasoumi, M., Najafgholizadeh, A., Clark, C. C. T., & Esmaillzadeh, A. (2021) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-021-03351-w · Cited by 59
Telephone Intervention to Improve Diabetes Control
Chamany, S., Walker, E. A., Schechter, C. B., Gonzalez, J. S., Davis, N. J., Ortega, F. M., Carrasco, J., Basch, C. E., & Silver, L. D. (2015) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2015.04.016 · Cited by 59
Chen, X., Li, C., He, T., Mao, J., Li, C., Lyu, J., & Meng, Q. H. (2016) · Cancer Biology & Therapy · doi:10.1080/15384047.2016.1156273 · Cited by 59
Nationwide trends in glucose-lowering drug use, Denmark, 1999–2014
Christensen, D. H., Rungby, J., & Thomsen, R. W. (2016) · Clinical Epidemiology · doi:10.2147/clep.s113211 · Cited by 59
Tabaei, B. P., Rundle, A., Wu, W. Y., Horowitz, C. R., Mayer, V., Sheehan, D. M., & Chamany, S. (2017) · American Journal of Epidemiology · doi:10.1093/aje/kwx300 · Cited by 59
Canagliflozin: A Review in Type 2 Diabetes
Deeks, E. D., & Scheen, A. J. (2017) · Drugs · doi:10.1007/s40265-017-0801-6 · Cited by 59
Colagiuri, S., Matthews, D. R., Leiter, L. A., Chan, S. P., Sesti, G., & Marre, M. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.05.028 · Cited by 59
Self-citation(2020) · International Review of Neurobiology · doi:10.1016/bs.irn.2020.02.010 · Cited by 58
Karagiannis, T., Liakos, A., Bekiari, E., Athanasiadou, E. A., Paschos, P., Vasilakou, D., Mainou, M., Rika, M., Boura, P., Matthews, D. R., et al. (2015) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12541 · Cited by 58
Self-citationZhang, Q., Li, S., Li, L., Li, Q., Ren, K., Sun, X., & Li, J. (2016) · Nutrients · doi:10.3390/nu8120798 · Cited by 58
Cardiovascular safety of non-insulin pharmacotherapy for type 2 diabetes
Xu, J., & Rajaratnam, R. (2017) · Cardiovascular Diabetology · doi:10.1186/s12933-017-0499-5 · Cited by 58
Gadde, K. M., Vetter, M. L., Iqbal, N., Hardy, E., Öhman, P., & on behalf of the DURATION‐NEO‐2 study investigators (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12908 · Cited by 58
Rapid Discovery of Potent and Selective Glycosidase-Inhibiting De Novo Peptides
Jongkees, S. A. K., Caner, S., Tysoe, C., Brayer, G. D., Withers, S. G., & Suga, H. (2017) · Cell chemical biology · doi:10.1016/j.chembiol.2017.02.001 · Cited by 58
Busch, R. S., & Kane, M. P. (2017) · Postgraduate Medicine · doi:10.1080/00325481.2017.1342509 · Cited by 58
Pharmacokinetics of metformin in patients with gastrointestinal intolerance
MCCREIGHT, L. J., Stage, T. B., Connelly, P. J., Lonergan, M. E., Nielsen, F., Prehn, C. P., Adamski, J., Brøsen, K., & Pearson, E. R. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13264 · Cited by 59
Perrin, N., Bodicoat, D. H., Davies, M. J., Robertson, N., Snoek, F. J., & Khunti, K. (2019) · Primary care diabetes · doi:10.1016/j.pcd.2019.04.001 · Cited by 58
Minimally and non-invasive glucose monitoring: the road toward commercialization
Min, S. Q., Geng, H., He, Y., Xu, T., Liu, Q., & Zhang, X. (2025) · Sensors & Diagnostics · doi:10.1039/d4sd00360h · Cited by 56
Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) in patients with Type 2 Diabetes Mellitus
Portillo-Sánchez, P., & Cusi, K. J. (2016) · Clinical Diabetes and Endocrinology · doi:10.1186/s40842-016-0027-7 · Cited by 57
Precision medicine: The future in diabetes care?
Scheen, A. J. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.04.033 · Cited by 57
Increasing Number of People with Diabetes in Japan: Is This Trend Real?
Goto, A., Noda, M., Inoue, M., Goto, M., & Charvat, H. (2016) · Internal Medicine · doi:10.2169/internalmedicine.55.6475 · Cited by 57
Tratamiento de la diabetes mellitus tipo 2 en el paciente anciano
Gómez‐Huelgas, R., Peralta, F. G., Rodríguez‐Mañas, L., Formiga, F., Puig‐Domingo, M., Bravo, J. J. M., Miranda, C., & Ena, J. (2018) · Revista Clínica Española · doi:10.1016/j.rce.2017.12.003 · Cited by 57
Sodium-glucose cotransporter 2 inhibitors: extending the indication to non-diabetic kidney disease?
Dekkers, C. C. J., & Gansevoort, R. T. (2019) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfz264 · Cited by 57
Cardiovascular protection in type 2 diabetes: Insights from recent outcome trials
Bailey, C. J., & Marx, N. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13492 · Cited by 56
Dujić, T., Zhou, K., Tavendale, R., Palmer, C. N. A., & Pearson, E. R. (2016) · Diabetes Care · doi:10.2337/dc16-0706 · Cited by 56
Mary, A., Hartemann, A., Liabeuf, S., Aubert, C. E., Kemel, S., Salem, J., Cluzel, P., Lenglet, A., Massy, Z. A., Lalau, J., et al. (2017) · Cardiovascular Diabetology · doi:10.1186/s12933-017-0509-7 · Cited by 56
Ji, L., Bonnet, F., Charbonnel, B. H., Gomes, M. B., Kosiborod, M., Khunti, K., Nicolucci, A., Pocock, S., Rathmann, W., Shestakova, M. V., et al. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.03.011 · Cited by 56
van Wijngaarden, R. P. T., Overbeek, J. A., Heintjes, E. M., Schubert, A., Diels, J., Straatman, H., Steyerberg, E. W., & Herings, R. M. C. (2017) · Diabetes Therapy · doi:10.1007/s13300-017-0301-4 · Cited by 56
Zhou, Q., Lei, X., Fu, S., Liu, P., Long, C., Wang, Y., Li, Z., Xie, Q., & Chen, Q. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-01198-4 · Cited by 55
Garber, A. J., Abrahamson, M. J., Barzilay, J. I., Blonde, L., Bloomgarden, Z. T., Bush, M. A., Dagogo-Jack, S. E., Davidson, M., EINHORN, D. F., Garber, J. R., et al. (2015) · Endocrine Practice · doi:10.4158/ep151063.cs · Cited by 55
Bode, B. W., & Garg, S. K. (2015) · Endocrine Practice · doi:10.4158/ep15869.ra · Cited by 55
Triple therapy in type 2 diabetes; a systematic review and network meta-analysis
Downes, M., Bettington, E. K., Gunton, J. E., & Turkstra, E. (2015) · PeerJ · doi:10.7717/peerj.1461 · Cited by 55
Precision Medicine in Diabetes: Is It Time?
Florez, J. C. (2016) · Diabetes Care · doi:10.2337/dc16-0586 · Cited by 55
Glucose Control and Vascular Outcomes in Type 2 Diabetes: Is the Picture Clear?
Giorgino, F., Home, P., & Tuomilehto, J. O. (2016) · Diabetes Care · doi:10.2337/dcs15-3023 · Cited by 55
Pharmacological Approaches in the Treatment and Maintenance of Weight Loss
Gaal, L. V., & Dirinck, E. L. (2016) · Diabetes Care · doi:10.2337/dcs15-3016 · Cited by 55
The effect of local hyperglycemia on skin cells in vitro and on wound healing in euglycemic rats
Kruse, C., Singh, M., Sørensen, J. A., Eriksson, E. K., & Nuutila, K. (2016) · Journal of Surgical Research · doi:10.1016/j.jss.2016.08.060 · Cited by 55
Tran, S., Retnakaran, R. R., Zinman, B., & Kramer, C. K. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13137 · Cited by 55
Treatment of type 2 diabetes: future approaches
Bailey, C. J., & Day, C. (2018) · British Medical Bulletin · doi:10.1093/brimed/ldy013 · Cited by 55
Kar, D., Gillies, C., Nath, M., Khunti, K., Davies, M. J., & Seidu, S. (2019) · Acta Diabetologica · doi:10.1007/s00592-019-01293-x · Cited by 55
A1C targets should be personalized to maximize benefits while limiting risks
Riddle, M. C., Gerstein, H. C., Holman, R. R., Inzucchi, S. E., Zinman, B., Zoungas, S., & Cefalu, W. T. (2018) · Diabetes Care · doi:10.2337/dci18-0018 · Cited by 54
Self-citationGelhorn, H. L., Poon, J. L., Davies, E. W., Paczkowski, R., Curtis, S., & Boye, K. S. (2015) · Patient Preference and Adherence · doi:10.2147/ppa.s90842 · Cited by 54
Nguyen, H. P., Dufour, R., & Caldwell-Tarr, A. (2017) · Advances in Therapy · doi:10.1007/s12325-016-0470-y · Cited by 54
Dalsgaard, N. B., Vilsbøll, T., & Knop, F. K. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13128 · Cited by 54
Rosenstock, J., Buse, J. B., Azeem, R., Prabhakar, P., Kjems, L., Huang, H., & Baron, M. A. (2017) · Diabetes Care · doi:10.2337/dc17-1306 · Cited by 53
Self-citationSheu, W. H., Chan, S. P., Matawaran, B. J., Deerochanawong, C., Mithal, A., Chan, J. C. N., Suastika, K., Khoo, C. M., Nguyen, H. M., Ji, L., et al. (2020) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2019.0208 · Cited by 53
Tajaddini, A., Roshanravan, N., Mobasseri, M., Aeinehchi, A., Azar, P. S., Hadi, A., & Ostadrahimi, A. (2021) · International Journal of Clinical Practice · doi:10.1111/ijcp.14334 · Cited by 53
Boye, K. S., Lage, M. J., Shinde, S., Thieu, V. T., & Bae, J. P. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01084-0 · Cited by 53
Cersosimo, E., Johnson, E. L., Chovanes, C., & Skolnik, N. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13108 · Cited by 52
Lin, J., Zhou, S., Wei, W., Pan, C., Lingohr-Smith, M., & Levin, P. (2016) · Endocrine Practice · doi:10.4158/ep15868.or · Cited by 52
Krishnan, A., Schneider, C. V., Hadi, Y. B., Mukherjee, D., Alshehri, B. Y., & Alqahtani, S. A. (2023) · Diabetologia · doi:10.1007/s00125-023-06057-5 · Cited by 52
Arakaki, R. F. (2016) · Postgraduate Medicine · doi:10.1080/00325481.2016.1167570 · Cited by 52
Treatment intensification for patients with type 2 diabetes and poor glycaemic control
Fu, A. Z., & Sheehan, J. J. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12683 · Cited by 52
Hypoglycaemia when adding sulphonylurea to metformin: a systematic review and network meta‐analysis
Andersen, S. E., & Christensen, M. (2016) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13059 · Cited by 52
Nunes, A. P., Yang, J., Radican, L., Engel, S. S., Kurtyka, K., Tunceli, K., Yu, S., Iglay, K., Doherty, M. C., & Dore, D. D. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.09.012 · Cited by 52
Wang, Y., Li, P., Tian, Y., Ren, J., & Li, J. (2016) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2016.2614991 · Cited by 52
Metadata
- Authors
- Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R.
- Affiliations
- Yale New Haven Hospital (US)
- Park Nicollet Health Services (US)
- University of North Carolina at Chapel Hill (US)
- Diabetes Center/Department of Internal Medicine, VU University Medical Center, Amsterdam, the Netherlands
- University of Pisa (IT)
- Diabeteszentrum Bad Lauterberg (DE)
- University of Southern California (US)
- Second Medical Department, Aristotle University Thessaloniki, Thessaloniki, Greece
- American Cancer Society (US)
- Churchill Hospital (GB)
- Corresponding author
- Inzucchi, Silvio E.
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2014-12-13
- Volume
- 38
- Issue
- 1
- Pages
- 140-149
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2160088494
- Cited by
- 3,066
- References
- 68
- Citations by year
- 2026: 52 · 2025: 84 · 2024: 96 · 2023: 135 · 2022: 138 · 2021: 142 · 2020: 202 · 2019: 313 · 2018: 482 · 2017: 545 · 2016: 540 · 2015: 325 · 2014: 7
- FWCI
- 380.40
- Type
- journal article
- Language
- en
- Open access
- green
- pure.amsterdamumc.nl
- Licence
- other-oa
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion, other-oa)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- Bristol-Myers Squibb
- Eli Lilly and Company
- AstraZeneca
- GlaxoSmithKline
- Sanofi
- Massachusetts General Hospital
- Yale University
- Kaiser Permanente
- F. Hoffmann-La Roche
- Case Western Reserve University
- School of Medicine, Case Western Reserve University
- Intarcia Therapeutics
- National Institute for Health and Care Research
- University of Sydney
- Universiteit van Amsterdam
- University of Toronto
- Novo Nordisk
- Uniwersytet Łódzki
- European Association for the Study of Diabetes
- Université de Nantes
- Servier
- Lilly Deutschland
- University of Ioannina
- School of Medicine, University of Kansas
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- type 2 diabetes, hyperglycemia management, antidiabetic drugs, patient-centered care, shared decision-making, glucose-lowering agents, cardiovascular risk reduction, smoking cessation, blood pressure control, lipid control, statins, antiplatelet therapy, lifestyle modification
- MeSH terms
- Clinical Trials as Topic, Diabetes Mellitus, Type 2, Drug Combinations, Humans, Hyperglycemia, Metformin, United States, Disease Management, Glycemic Index, Thiazolidinediones, Dipeptidyl-Peptidase IV Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
